Objective To explore the necessity and feasibility of the real-time treatment planning optimization by CT guided with 125I seed implantation brachytherapy treatment to thoracic malignancies. Methods To retrospectively analyze the data of 31 inpatients (from October 2010 to June 2012) with thoracic malignancie by CT guidance 125I brachytherapy. The real-time planning optimization were applicated to 13 cases (group A), 18 patients undergoing experience particles implantation interval 1 cm (group B), all the patients were prescribed dose 110 Gy and post-planning verified after surgery. Re-simulation of real-time program (group C) about the image data in group B, data analysis was χ2-test by SPSS 13.0 software. Results The quality verification in two groups were 92% and 39%,the difference was statistically sifnificant (P=0.003). The re-simulation program in group C was 94%,there was significant difference compared with group B (P=0.001),but with no significant difference compared with group A (P=0.811). Conclusions The application of intraoperative real-time planning by CT guided with 125I seed implantation brachytherapy to thoracic malignancies, non-equidistant layout that be the real implantedneedle trajectory based on dosimetry, can significantly improve the tumor target dose, operational, there was greatly important value to the standardization of the particle therapy of thoracic malignancies.
Corresponding Authors:
CHAI Shu-de,Department of Thoracic Surgery,Second Hospital of Tianjin Medical University;Email:shudeichaisd@sina.com
Cite this article:
HUO Bin,HOU Zhao-hua,YE Jian-fei et al. The study of intraoperative real-time planning by CT-guided in 125I seed implantation for thoracic malignancie[J]. Chinese Journal of Radiation Oncology, 2013, 22(5): 400-402.
HUO Bin,HOU Zhao-hua,YE Jian-fei et al. The study of intraoperative real-time planning by CT-guided in 125I seed implantation for thoracic malignancie[J]. Chinese Journal of Radiation Oncology, 2013, 22(5): 400-402.
[1]Trombetta MG, Colonias A, Makishi D,et al.Toleranee of the aorta using intraoperative Iodine-125 interstitial brachytherapy in cancer of the lung.Brachytherapy,2008,7:50-54. [2]Wang J, Jiang Y, Li J, et al.Intraoperative ultrasound-guided iodine-125 seed implantation for unresectable pancreatic carcinoma.J Exp Clin Cancer Res,2009,28:88. [3]Older RA, Synder B, Krupski TL, et al. Radioactive implant migration inpatients treated for localized prostate cancer with interstitial brachytherapy. J Urol,2001,165:1590-1592. [4]Lee W, Daly BD, DiPetrillo TA, et al.Limited resection for non-small cell lung cancer:observed local control with implantation of I-125 brachytherapy seeds. Ann Thorac Surg,2003,75:237-243. [5]Darakchiev BJ, Albright RE, Breneman JC, et al.Safety andefficacy of permanent iodine-125 seed implants andcarmustine wafers in patients with recurrent glioblastoma multiforme. Neurosurg,2008,108:236-242. [6]Nag S, Bice WS, Degaert K, et al.The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys,2000,46:221-230 [7]申文江.放射性粒子植入的临床应用//柴树德,郑广钧,王俊杰,等.放射性粒子植入治疗胸部肿瘤.北京:人民卫生出版社,2012:8-9. [8]Lee EK, Zaider M.Intraoperative dynamic dose optimization in permanent prostate implants. Int J Radiat Oncol Biol Phys,2003,56:854-861. [9]王娟,王绍其,徐建彬,等.125I粒子不同分布组织间植入对荷人胃癌裸鼠移植瘤疗效的影响.中华核医学杂志,2008,28:313,316. [10]王俊杰,田素青,李金娜,等.放射性125I粒子平面插植布源剂量分布研究.中国微创外科杂志,2005,12:1061,1062. [11]王娟,张宏涛,赵文清,等.125I粒子平面布源剂量学研究.中华核医学杂志,2010,10:339-342.